Russia and India are in Close Talks for Mass Production of COVID-19 Drug


India and Russia are in close talks with each other. And the prediction says that a joint announcement on the combined production of Covid-19 drug is on its way soon.

The sputnik-5 vaccine is the first-ever successful Covid-19 drug to be registered and it’s manufactured by Russia.

Russia and India are in Close Talks for Mass Production of COVID-19 Drug

The drug has been developed by Gamaleya Research Institute and the Russian defense ministry. They’ve registered the drug but it’s still under trials.

Now, the current status of the drug is that it is in its Phase 3 trial needing 40,000 people at more than 45 medical centers around Russia.

It is a potential aid for the world because it is showing positive results until now. And on top of that Russian President, Putin puts enough faith in this potential vaccine that he put it in his daughter.

Kirill Dmitriev, CEO, Russian Direct Investment Fund today said, “We are having a close dialogue with corresponding ministries and Indian government and its leading manufactures regarding localization of production of Sputnik V vaccine,”

“We do recognize India’s potential to become a support for the production of the vaccine not only in Indian markets but for other countries too and we have achieved certain agreements with the leading companies,” he further added.

The trust upon India from the Russian side is not just on the basis of good intercounty relations but actually based on the massive potential India has.

It’s a lesser-known fact that about 60% of the world’s total vaccines are manufactured in India. And if anyone has the potential to manufacture COVID-19 not just for two countries but for the world than it got to be India only.

“As far as Sputnik-5 vaccine is concerned, India and Russia are in communication. Some initial information has been shared,” said Rajesh Bhushan, Secretary, Union Health Ministry.

What is exactly going on and when will the drug be out is still unknown to the general masses. But it’s one thing for sure and that’s India and Russia, both are giving positive vibes on the news of collaborative effort in the production of the COVID-19 drug. Let’s hope for the best and keep our fingers crossed for now.


Follow Flickonclick on Google News

Related articles

Updated COVID Guidelines For Noida: Things You Should Know

In the third week of November 2021, India reported 7,000 to 9,000 new COVID-19 cases every day. The...

Do You Need The Vaccine If You Have Already Recovered from Covid-19?

It has been advised by the Union health ministry that those who have recovered from COVID-19, doesn’t matter...

Reliance Offers Relief Package to the Family of Deceased Employees Includes Salary for Next 5 Years and More

The second wave of Covid has struck bad and this time as well we have a significant loss...

Covid-19 Omicron Variant: First 2 cases detected in Karnataka, India

India has registered its first two Omicron variant Covid cases as of now. Importantly, the country has been...

Unlock 4.0: Metro Starting Operation From 7th September, New Guidelines and More

Unlock 4.0 is finally here and we are steadily heading towards a fully unlocked condition. The biggest highlight...

What is Mucurmycosis, Is it an After-effect of COVID-19?

There is a rare black fungus affecting people who are suffering from COVID-19. The first case that was...

Delhi Covid-19 Vaccination: The Inoculation Will Be Done Four Times A Week

After reviewing the COVID-19 situation in Delhi, Chief Minister Arvind Kejriwal made it clear in a conference that...

Lockdown Extension: Activities Allowed and Prohibited According to Zone Division

Everyone already had the clue that the lockdown would be extended even after the 3rd of May and...